SCHEMBL21020463

SCHEMBL21020463

COc1ccc(CN2C=C(c3nc([S+]([O-])CCC(OCc4ccccc4F)c4ccccc4)nc4sccc34)C=C(F)C2O)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19806011 0.82 SMN1; SMN2 (0.33) —
SCHEMBL29976343 0.82 SMN1; SMN2 (0.33) —
SCHEMBL20985635 0.70 SDHB (0.33) —
SCHEMBL20985672 0.67 SDHB (0.37) —
SCHEMBL30526073 0.67 SDHB (0.37) —
SCHEMBL21019948 0.62 SIGMAR1 (0.31) —
SCHEMBL21019833 0.62 — —
SCHEMBL21019752 0.62 — —
SCHEMBL20985699 0.62 SDHB (0.36) —
SCHEMBL28306288 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 — — US disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 — — US disclosed
Send feedback